Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study.

Saved in:
Bibliographic Details
Title: Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study.
Authors: Baez-Navarro X; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands. Electronic address: x.baeznavarro@erasmusmc.nl., van Bockstal MR; Department of Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Nawawi D; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., Broeckx G; Department of Pathology, Antwerp University Hospital, Edegem, Belgium., Colpaert C; Department of Pathology, General Hospital Turnhout, Turnhout, Belgium; Department of Pathology, University Hospital Leuven, Leuven, Belgium., Doebar SC; Department of Pathology, Spaarne Gasthuis, Haarlem Zuid, The Netherlands., Hogenes MCH; Department of Pathology, Laboratory Pathology East Netherlands, Hengelo, The Netherlands., Koop E; Department of Pathology, Gelre Hospital, Apeldoorn, The Netherlands., Lambein K; Department of Surgical Oncology, Leuven University Hospitals, Leuven, Belgium; Department of Pathology, Ghent University Hospital, Ghent, Belgium., Peeters DJE; Department of Pathology, Sint-Maarten General Hospital, Mechelen, Belgium; Department of Pathology, CellCarta NV, Antwerp, Belgium., Sinke RHJA; Department of Pathology, Pathan B.V., Rotterdam, The Netherlands., Bastiaan van Brakel J; Department of Pathology, Skåne University Hospital, Malmö, Sweden., van der Starre-Gaal J; Department of Pathology, Isala Clinics, Zwolle, The Netherlands., van der Vegt B; Department of Pathology & Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., van de Vijver K; Department of Surgical Oncology, Leuven University Hospitals, Leuven, Belgium; Division of Diagnostic Sciences, Cancer Research Institute Ghent, Ghent University, Ghent, Belgium., Vreuls CPH; Department of Pathology, Utrecht University Medical Center, Utrecht, The Netherlands., Vreuls W; Department of Pathology, CWZ Hospital, Nijmegen, The Netherlands., Westenend PJ; Department of Pathology, PAL Laboratory of Pathology, Dordrecht, The Netherlands., van Deurzen CHM; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Source: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2023 Jan; Vol. 36 (1), pp. 100009.
Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-0285
DOI:10.1016/j.modpat.2022.100009